{"prompt": "['Alliance A221701', 'If using NCI CIRB, rostered on the NCI CIRB Signatory record;', 'Includes the IRB number of the IRB providing approval in the Form FDA 1572', 'in the RCR profile; and', 'Holds the appropriate CTEP registration type for the protocol.', '4.2.1', 'Additional site registration requirements', 'Additional requirements to obtain an approved site registration status include:', 'An active Federal Wide Assurance (FWA) number;', 'An active roster affiliation with the Lead Protocol Organization (LPO) or a', 'Participating Organization (PO); and', 'Compliance with all protocol-specific requirements (PSRs).', '4.2.2', 'Protocol Specific Requirements for Site Registration', 'Limited access information', 'With Update 2 to the protocol, this is a limited access study. Institutions that have', 'previously enrolled participants and have expressed continued interest in participating in', 'this study have been identified and listed on Page 2 of the protocol.', '4.2.3', 'Downloading Site Registration Documents', 'Download the site registration forms from the protocol-specific page located on the CTSU', \"members' website. Permission to view and download this protocol and its supporting\", 'documents is restricted based on person and site roster assignment. To participate, the', 'institution and its associated investigators and staff must be associated with the LPO or a', 'Protocol Organization (PO) on the protocol. One way to search for a protocol is listed', 'below.', \"Log in to the CTSU members' website\", 'using your CTEP-IAM', 'username and password;', 'Click on Protocols in the upper left of the screen', 'Enter the protocol number in the search field at the top of the protocol tree;', 'or', 'Click on the By Lead Organization folder to expand, then select [Alliance],', 'and protocol number [A221701].', 'Click on Documents, select Site Registration, and download and complete the forms', 'provided. (Note: For sites under the CIRB, IRB data will load automatically to the', 'CTSU.)', '4.2.4', 'Submitting regulatory documents', 'Submit required forms and documents to the CTSU Regulatory Office using the Regulatory', 'Submission Portal on the CTSU website.', \"To access the Regulatory Submission Portal log in to the CTSU members' website, go to\", 'the Regulatory section and select Regulatory Submission.', 'Institutions with patients waiting that are unable to use the Regulatory Submission Portal', 'should alert the CTSU Regulatory Office immediately at', 'in order to', 'receive further instruction and support.', '18', 'NCI version date 8/14/2020', 'Update #03']['Alliance A221701', \"4.2.5 Checking your site's registration status\", \"Site registration status may be verified on the CTSU members' website.\", 'Click on Regulatory at the top of the screen;', 'Click on Site Registration; and', 'Enter the sites 5-character CTEP Institution Code and click on Go.', 'Additional filters are available to sort by Protocol, Registration Status,', 'Protocol Status, and/or IRB Type.', 'Note: The status shown only reflects institutional compliance with site registration', 'requirements as outlined within the protocol. It does not reflect compliance with protocol', \"requirements for individuals participating on the protocol or the enrolling investigator's\", 'status with NCI or their affiliated networks.', '4.3', 'Patient Registration Requirements', 'Informed consent: the patient must be aware of the neoplastic nature of his/her disease and', 'willingly consent after being informed of the procedure to be followed, the experimental nature', 'of the therapy, alternatives, potential benefits, side-effects, risks, and discomforts. Current', 'human protection committee approval of this protocol and a consent form is required prior to', 'patient consent and registration.', 'Patient completed booklets: Patient questionnaire booklets are to be ordered prior to the', 'registration of any patients. Patient completed booklets can be ordered by downloading and', 'completing the CTSU supply request form (located under the site registration documents section', 'of the A221701 CTSU site) and submitting it through the CTSU regulatory portal. Samples of', 'the questionnaires included in the booklets are found in Appendices II-V, which are to be used', 'for reference and IRB submission only. They are not to be used for patient completion.', 'Protected Health Information: Whole blood samples collected for the pharmacokinetics sub-', 'study A221701-PP1 will be sent directly to the University of Pittsburgh Cancer Center. These', 'samples will be labeled with patient initials, study ID and collection date/time.', '4.4', 'Patient Enrollment (registration/randomization procedures (Step 1))', 'The Oncology Patient Enrollment Network (OPEN) is a web-based registration system available', 'on a 24/7 basis. OPEN is integrated with CTSU regulatory and roster data and with the LPOs', 'registration/randomization systems or the Theradex Interactive Web Response System (IWRS)', 'for retrieval of patient registration/randomization assignment. OPEN will populate the patient', \"enrollment data in NCI's clinical data management system, Medidata Rave.\", 'Requirements for OPEN access:', 'A valid CTEP-IAM account;', 'To perform enrollments or request slot reservations: Must be on an LPO roster, ETCTN', 'corresponding roster, or participating organization roster with the role of Registrar.', 'Registrars must hold a minimum of an Associate Plus (AP) registration type;', 'If a Delegation of Tasks Log (DTL) is required for the study, the registrars must hold', 'the OPEN Registrar task on the DTL for the site; and', 'Have an approved site registration for the protocol prior to patient enrollment.', 'To assign an Investigator (IVR) or Non-Physician Investigator (NPIVR) as the treating,', 'crediting, consenting, drug shipment (IVR only), or receiving investigator for a patient transfer', '19', 'NCI version date 8/14/2020', 'Update #03']\n\n###\n\n", "completion": "END"}